Quarterly report · Q1
2689.TEDINET S100PJIX
Period2022-07-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥26.3bn | 2022-07-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥108.0bn | 2021-07-01 → 2022-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥25.0bn | 2021-07-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥403m | 2022-07-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥249m | 2021-07-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥404m | 2022-07-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.1bn | 2021-07-01 → 2022-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥257m | 2021-07-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥402m | 2022-07-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥242m | 2021-07-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥251m | 2022-07-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.5bn | 2021-07-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥175m | 2021-07-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥251m | 2022-07-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥175m | 2021-07-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥38.5bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥40.0bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥38.3bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥29.5bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥30.9bn | at 2022-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥9.0bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥9.1bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥8.0bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.2bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.2bn | at 2022-06-30 | Cons. | Cash and deposits |
| EPS (basic) | ¥41.84 | 2022-07-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥252.8 | 2021-07-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28.81 | 2021-07-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 23.3% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.8% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 20.9% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 38
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-07-01 → 2022-09-30 | −¥394m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-07-01 → 2022-09-30 | −¥394m |
| Reconciling Itemsreconciling | segment profit | 2022-07-01 → 2022-09-30 | −¥38m |
| jpcrp040300-q1r_E02928-000Care Nursing Goodsreportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥616m |
| jpcrp040300-q1r_E02928-000Care Nursing Goodsreportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥616m |
| jpcrp040300-q1r_E02928-000Care Nursing Goodsreportable segment | revenue intersegment | 2022-07-01 → 2022-09-30 | ¥23,000 |
| jpcrp040300-q1r_E02928-000Care Nursing Goodsreportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥47m |
| jpcrp040300-q1r_E02928-000Medical Equipmentreportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥24.8bn |
| jpcrp040300-q1r_E02928-000Medical Equipmentreportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥24.5bn |
| jpcrp040300-q1r_E02928-000Medical Equipmentreportable segment | revenue intersegment | 2022-07-01 → 2022-09-30 | ¥363m |
| jpcrp040300-q1r_E02928-000Medical Equipmentreportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥347m |
| jpcrp040300-q1r_E02928-000SPDreportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥1.2bn |
| jpcrp040300-q1r_E02928-000SPDreportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥1.2bn |
| jpcrp040300-q1r_E02928-000SPDreportable segment | revenue intersegment | 2022-07-01 → 2022-09-30 | ¥32m |
| jpcrp040300-q1r_E02928-000SPDreportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥47m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-07-01 → 2022-09-30 | ¥26.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-07-01 → 2022-09-30 | ¥26.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-07-01 → 2022-09-30 | ¥394m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-07-01 → 2022-09-30 | ¥441m |
| Reconciling Itemsreconciling | revenue | 2021-07-01 → 2021-09-30 | −¥342m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-07-01 → 2021-09-30 | −¥342m |
| Reconciling Itemsreconciling | segment profit | 2021-07-01 → 2021-09-30 | −¥48m |
| jpcrp040300-q1r_E02928-000Care Nursing Goodsreportable segment | revenue | 2021-07-01 → 2021-09-30 | ¥582m |
| jpcrp040300-q1r_E02928-000Care Nursing Goodsreportable segment | revenue external | 2021-07-01 → 2021-09-30 | ¥582m |
| jpcrp040300-q1r_E02928-000Care Nursing Goodsreportable segment | revenue intersegment | 2021-07-01 → 2021-09-30 | ¥14,000 |
| jpcrp040300-q1r_E02928-000Care Nursing Goodsreportable segment | segment profit | 2021-07-01 → 2021-09-30 | ¥39m |
| jpcrp040300-q1r_E02928-000Medical Equipmentreportable segment | revenue | 2021-07-01 → 2021-09-30 | ¥23.6bn |
| jpcrp040300-q1r_E02928-000Medical Equipmentreportable segment | revenue external | 2021-07-01 → 2021-09-30 | ¥23.3bn |
| jpcrp040300-q1r_E02928-000Medical Equipmentreportable segment | revenue intersegment | 2021-07-01 → 2021-09-30 | ¥311m |
| jpcrp040300-q1r_E02928-000Medical Equipmentreportable segment | segment profit | 2021-07-01 → 2021-09-30 | ¥231m |
| jpcrp040300-q1r_E02928-000SPDreportable segment | revenue | 2021-07-01 → 2021-09-30 | ¥1.2bn |
| jpcrp040300-q1r_E02928-000SPDreportable segment | revenue external | 2021-07-01 → 2021-09-30 | ¥1.1bn |
| jpcrp040300-q1r_E02928-000SPDreportable segment | revenue intersegment | 2021-07-01 → 2021-09-30 | ¥31m |
| jpcrp040300-q1r_E02928-000SPDreportable segment | segment profit | 2021-07-01 → 2021-09-30 | ¥28m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-07-01 → 2021-09-30 | ¥25.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-07-01 → 2021-09-30 | ¥25.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-07-01 → 2021-09-30 | ¥342m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-07-01 → 2021-09-30 | ¥298m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 354
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)有限責任 あずさ監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)神 田 正 史 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)福 島 康 生 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 25013186000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 26307999000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 107959426000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 257453000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 404156000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 2119844000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 175280000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 251459000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 1535333000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 196219000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 248972000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 1432248000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 7993026000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 8982861000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 9093306000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 38261214000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 38531682000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 39968672000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 28.81 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 41.84 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 252.80 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.209 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.233 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.228 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 6250000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 6250000 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 6250000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 6250000 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 131100 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 6114400 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 61144 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 4500 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 6250000 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 61144 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 131100 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 131100 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.0210 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |